# US 2019/0055190 A1 · Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety and novel intermediates and methods related thereto

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0055190 A1
- Document ID: US20190055190A1
- Status: Published application
- Kind: A1
- Application number: 16/037,953
- Filed: 2018-07-17
- Published: 2019-02-21
- Earliest claimed: 2017-07-17
- Assignees: Trucode Gene Repair, Inc.
- Applicants: Trucode Gene Repair, Inc.
- Inventors: James M. Coull; Brian D. Gildea
- Web page: https://patentgrep.com/patent/US20190055190A1

## CPC

- C07C 229/08: the nitrogen atom of the amino group being further bound to hydrogen atoms
- C07C 213/08: by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
- C07C 215/08: with only one hydroxy group and one amino group bound to the carbon skeleton
- C07C 221/00: Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C 225/06: and acyclic
- C07C 227/18: by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C 229/26: having more than one amino group bound to the carbon skeleton, e.g. lysine
- C07C 269/06: by reactions not involving the formation of carbamate groups
- C07C 271/20: to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C07C 309/30: of six-membered aromatic rings substituted by alkyl groups
- C07D 239/47: One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- C07D 239/54: as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D 473/06: with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D 473/18: one oxygen and one nitrogen atom, e.g. guanine
- C07D 473/34: attached in position 6, e.g. adenine
- C07C 2603/18: Fluorenes; Hydrogenated fluorenes
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present disclosure pertains to peptide nucleic acid (PNA) monomers and oligomers, as well as methods and compositions useful for the preparation of PNA monomer precursors (e.g. PNA Monomer Esters, Backbone Esters and Backbone Ester Acid Salts, as described below) that can be used to prepare PNA monomers wherein said PNA monomers can be used to prepare said PNA oligomers. In some embodiments, the disclosure features sulfonic acid salts of Backbone Ester compounds, which sulfonic acid salts generally tend to be crystalline and can be obtained in reasonably good yield, often without requiring any chromatographic purification of the reaction product of the Backbone Ester synthesis reaction. This disclosure also pertains to novel methods for the synthesis of said Backbone Ester compounds and novel methods for the formation of the related sulfonic acid salts. Exemplary ester groups include, but are not limited to, 2,2,2-trichloroethy-(TCE), 2,2,2-tribromoethyl-(TBE), 2-iodoethyl-groups (2-IE) and 2-bromoethyl-(2-BrE) as the ester group. These particular ester groups can be removed under conditions where both Boc and Fmoc protected amine groups are stable.

## Claims

### Claim 1

A compound of formula VI:
wherein:
Y− is a sulfonate anion;
Pg1 is an amine protecting group;
R101 is a branched or straight chain C1-C4 alkyl or a group of formula I;
wherein, each R11 is independently H, D, F, C1-C6 alkyl, C3-C6 cycloalkyl or aryl; each of R12, R13 and R14 is independently selected from the group consisting of: H, D, F, C1, Br and I, provided however that at least one of R12, R13 and R14 is selected from C1, Br and I;
R2 is H, D or C1-C4 alkyl;
each of R3, R4, R5, and R6 is independently selected from the group consisting of: H, D, F, and a side chain selected from the group consisting of: IIIa, IIIb, IIIc, IIId, IIIe, IIIf, IIIg, IIIh, IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy, IIIz, IIIaa, and IIIab, wherein each of IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy and IIIz optionally comprises a protecting group;
wherein, R16 is selected from H, D and C1-C4 alkyl; and
n is a number from 0 to 10, inclusive.

### Claim at position 2

2-3. (canceled)

### Claim 4 (depends on 1)

The compound of claim 1, wherein Y− is selected from benzenesulfonate, p-toluenesulfonate, naphthalenesulfonate, p-xylene-2-sulfonate, 2,4,5-trichlorobenzenesulfonate, 2,6-dimethylbenzenesulfonate, 2-mesitylenesulfonate, 2-mesitylenesulfonate dihydrate, 2-methylbenzene sulfonate, 2-ethylbenzenesulfonate, 2-isopropylbenzenesulfonate, 2,3-dimethylbenzenesulfonate, 2,4,6-trimethylbenzenesulfonate, and 2,4,6-triisopropylbenzenesulfonate.

### Claim 5 (depends on 1)

The compound of claim 1, wherein Y− is p-toluenesulfonate.

### Claim at position 5

6-7. (canceled)

### Claim 8 (depends on 1)

The compound of claim 1, wherein R2 is H or D.

### Claim at position 7

9-11. (canceled)

### Claim 12 (depends on 1)

The compound of claim 1, wherein Pg1 is Fmoc.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The compound of claim 1, wherein Pg1 is Boc.

### Claim 15 (depends on 1)

The compound of claim 1, wherein R10 is 2,2,2-trichloroethyl, 2,2,2-tribromoethyl, 2-iodoethyl or 2-bromoethyl.

### Claim 16 (depends on 1)

The compound of claim 1;
wherein one of R3, R4, R5 and R6 is independently selected from the group consisting of: IIIa, IIIb, IIIc, IIId, IIIe, IIIf, IIIg, IIIh, IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy, IIIz, IIIaa, and IIIab, wherein each of IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy and IIIz optionally comprises a protecting group; and
the others of R3, R4, R5 and R6 are independently H, D or F.

### Claim 17

(canceled)

### Claim 18 (depends on 1)

The compound of claim 1, wherein one of R3 or R4 is a group of formula IIIaa or IIIab:
and the other of R3 and R4 is H, wherein, n is 0, 1, 2, 3 or 4 and R16 is H, methyl or t-butyl.

### Claim 19 (depends on 16)

The compound of claim 16, wherein Pg1 is selected from the group consisting of: Nsc, Bsmoc, Nsmoc, ivDde, Boc, Fmoc, Fmoc*, Fmoc(2F), mio-Fmoc, dio-Fmoc, TCP, Pms, Esc, Sps, Cyoc, Trt, Ddz, Bpoc, Nps, Bhoc, Dmbhoc and Floc.

### Claim 20 (depends on 16)

The compound of claim 16, wherein Pg1 is Fmoc.

### Claim at position 17

21-22. (canceled)

### Claim 23 (depends on 16)

The compound of claim 16, wherein Y− sulfonate anion is p-toluenesulfonate.

### Claim 24 (depends on 16)

The compound of claim 16, wherein R101 is 2,2,2-trichloroethyl-, 2,2,2-tribromoethyl-, 2-iodoethyl- or 2-bromoethyl.

### Claim 25 (depends on 1)

A kit comprising: a) a compound according to claim 1; and
b) (i) instructions; (ii) a nucleobase acid; and/or (iii) a solvent.

### Claim 26

A compound of formula VI-T:
wherein, Pg1 is an amine protecting group;
R101 is selected from the group consisting of: methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, allyl, 2-iodoethyl, 2-bromoethyl, 2,2,2-trichloroethyl, 2,2,2-trifluoroethyl, 2,2,2-tribromoethyl and tert-butyldimethylsilyl;
R2 is H, D or C1-C4 alkyl;
each R2′ is independently H, D, F, Cl, Br, I or C1-C4 alkyl; and
each of R3, R4, R5, and R6 is independently selected from the group consisting of: H, D, F, and a side chain selected from the group consisting of: IIIa, IIIb, IIIc, IIId, IIIe, IIIf, IIIg, IIIh, IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy, IIIz, IIIaa, and IIIab, wherein each of IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy and IIIz optionally comprises a protecting group;
wherein, R16 is selected from H, D and C1-C4 alkyl; and
n is a number from 0 to 10, inclusive.

### Claim 27

A compound of formula VI-Ts:
wherein, Pg1 is an amine protecting group;
R101 is selected from the group consisting of: methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, allyl, 2-iodoethyl, 2-bromoethyl, 2,2,2-trichloroethyl, 2,2,2-trifluoroethyl, 2,2,2-tribromoethyl and tert-butyldimethylsilyl;
R2 is H, D or C1-C4 alkyl; and
each of R3, R4, R5, and R6 is independently selected from the group consisting of: H, D, F, and a side chain selected from the group consisting of: IIIa, IIIb, IIIc, IIId, IIIe, IIIf, IIIg, IIIh, IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy, IIIz, IIIaa, and IIIab, wherein each of IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy and IIIz optionally comprises a protecting group;
wherein, R16 is selected from H, D and C1-C4 alkyl; and
n is a number from 0 to 10, inclusive.

### Claim 28 (depends on 27)

The compound of claim 27, wherein at least one of R3 and R4 is independently selected from the group consisting of formulas IIIaa and IIIab.

### Claim at position 24

29-51. (canceled)

### Claim 52 (depends on 27)

The compound of claim 27, wherein the compound of formula VI-Ts is selected from the group consisting of:
wherein, each of R12, R13 and R14 is independently H, D, F, Cl, Br or I, provided however that at least one of R12, R13 and R14 is selected from Cl, Br and I.

### Claim at position 26

53-63. (canceled)

### Claim 64

A method comprising:
(i) reacting a compound of formula 53a:
with a compound of formula 52a:
wherein PgB is a base-labile amine protecting group; R101 is a branched or straight chain C1-C4 alkyl or a group of formula I;
wherein,
each R11 is independently H, D, F, C1-C6 alkyl, C3-C6 cycloalkyl or aryl;
each of R12, R13 and R14 is independently H, D, F, Cl, Br or I, provided however that at least one of R12, R13 and R14 is selected from Cl, Br and I; and
Y− is an anion;
(ii) wherein the reaction proceeds in the presence of a tertiary base and wherein the reaction produces a product of formula 54a:

### Claim 65 (depends on 64)

The method of claim 64, further comprising: contacting the compound of formula 54a with at least one equivalent of a sulfonic acid to thereby produce a compound of formula 55a:
wherein, PgB is a base-labile amine protecting group; R101 is a branched or straight chain C1-C4 alkyl or a group of formula I;
wherein, each R11 is independently H, D, F, C1-C6 alkyl, C3-C6 cycloalkyl or aryl;
each of R12, R13 and R14 is independently H, D, F, Cl, Br or I, provided however that at least one of R12, R13 and R14 is selected from Cl, Br and I; and
SA− is a sulfonate anion.

### Claim at position 29

66-72. (canceled)

### Claim 73

A method of preparing a compound of formula II:
or a pharmaceutically acceptable salt thereof, wherein, B is a nucleobase, optionally comprising one or more protecting groups;
Pg1 is an amine protecting group;
R1 is a group of formula I;
wherein,
each R11 is independently H, D, F, C1-C6 alkyl, C3-C6 cycloalkyl or aryl;
each of R12, R13 and R14 is independently H, D, F, Cl, Br or I, provided however that at least one of R12, R13 and R14 is selected from Cl, Br and I;
R2 is H, D or C1-C4 alkyl;
each of R3, R4, R5, and R6 is independently selected from the group consisting of: H, D, F, and a side chain selected from the group consisting of: IIIa, IIIb, IIIc, IIId, IIIe, IIIf, IIIg, IIIh, IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy, IIIz, IIIaa and IIIab, wherein each of IIIi, IIIj, IIIk, IIIm, IIIn, IIIo, IIIp, IIIq, IIIr, IIIs, IIIt, IIIu, IIIv, IIIw, IIIx, IIIy, and IIIz optionally comprise a protecting group;
wherein, each of R9 and R10 is independently selected from the group consisting of: H, D and F;
R16 is selected from H, D and C1-C4 alkyl; and
n is a whole number from 0 to 10, inclusive, comprising:
a) providing a compound of formula VI:
wherein each of Pg1, R101, R2, R3, R4, R5, and R6 are as defined, and Y− is a sulfonate anion;
b) contacting the compound of formula VI with a nucleobase acid of formula IX:
wherein each of R9, R101 and B are as defined;
in the presence of a carboxylic acid activation agent and a base to form a compound of formula II.

### Claim at position 31

74-75. (canceled)

### Claim 80 (depends on 1)

A method of evaluating a preparation of a compound of formula VI:
wherein each of Pg1, R101, R2, R3, R4, R5, R6, and Y− are as defined in claim 1; comprising:
a) acquiring a value for the level of an impurity;
b) evaluating the level of the impurity by comparing the value of the level of the impurity with a reference value;
thereby evaluating the preparation.

### Claim at position 33

81-85. (canceled)
